Business · 26/06/2024
FDA Announces Final Guidance for Priority Zoonotic Animal Drug Designation and Review Process
The FDA has released a final guidance document to help pharmaceutical companies navigate the process of obtaining Priority Zoonotic Animal Drug (PZAD) designation for new animal medications, which aims to expedite the review of drugs that can prevent or treat zoonotic diseases.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →